Key players operating in the global legionella testing market
include IDEXX Laboratories, Inc., Becton, Dickinson and Company, Thermo
Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., BioMérieux Inc.,
and Qiagen N.V., among others. The legionella testing market is likely
to retain a high degree of fragmentation in the coming years due to the
lucrative prospects on offer in medical research facilities across a
number of countries.
According to Transparency Market
Research, the global legionella testing market was valued at US$180
million in 2016 and is estimated to reach US$398.7 million by 2025 at a
CAGR of 9.4% from 2017 to 2025.
The increase in the number of legionella
patients in North America and the presence of several of the legionella
testing industry’s key players has led to steady dominance of the region
in the global legionella testing market. For instance, in 2015, nearly
6000 people were diagnosed with Legionnaire’s disease in the United
States alone. Moreover, the supportive stance of European countries such
as the UK, France, and Germany towards advanced healthcare research has
allowed them to gain an important place in the global legionella
testing market. In Asia Pacific and Latin America, increased awareness
about healthcare has led to precautions being taken for early diagnosis
of the disease and a rise in investments in the healthcare sector, which
has led to rapid growth of the legionella testing market.
Rising Awareness about Ubiquity of Legionella Bacteria Drives Legionella Testing Market
Legionella bacteria are widespread in
natural water bodies such as ponds and rivers. Inhalation of aerosol
water particles containing legionella bacteria is a common way of
contracting the pathogen. The rising awareness regarding the risk of
contracting legionella-borne diseases from water bodies is a vital
driver for the global legionella testing market.
Technological advancements are boosting
innovative microfluidic platforms which help provide satisfaction,
safety, and stability to patients. Growing availability of up-to-date
treatment facilities and rise in the number of skilled doctors,
consultants, and healthcare services are helping drive the legionella
testing market.
High Costs, Lack of Reimbursement Hamper Legionella Testing Market in Developing Countries
The incidence rate of several infectious
diseases is increasing globally, particularly in developing regions.
Indications such as waterborne, airborne, respiratory, and sexually
transmitted diseases are increasing at an alarming rate in countries
across the globe. Highly populous regions such as APAC, MEA, and Latin
America have a high incidence of infectious diseases, which is leading
to a steady increase in the demand for diagnostic kits. Thus, the global
legionella testing market is expected to witness substantial growth
over the forecast period.
Currently, the incidence rate of
infectious diseases is minimal in developed countries due to the
availability of better healthcare and lifestyle standards. However,
transmission of diseases across regions through migration is increasing,
which in turn is expected to fuel demand for diagnostic tests and kits
in these regions. Additionally, increasing healthcare spending is
expected to result in increasing demand for better and faster legionella
testing and diagnostic methods, and in turn create high growth
opportunities for players in the global legionella testing market over
the forecast period. However, rise in the cost of treatment, lack of
reimbursement policies for legionella testing in developing regions, and
side effects associated with legionella treatment are restraining the
growth of the market.
No comments:
Post a Comment